Serum galactomannan in cystic fibrosis patients colonized withAspergillusspecies

Stenotrophomonas maltophiliain Cystic Fibrosis

(2010) Valerie Waters et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Initial 96 Hours of Invasive Pulmonary Aspergillosis: Histopathology, Comparative Kinetics of Galactomannan and (1->3)- -D-Glucan, and Consequences of Delayed Antifungal Therapy

(2010) W. W. Hope et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis: State of the art and further challenges

(2010) Laurence Delhaes et al.   MEDICAL MYCOLOGY

INVASIVE ASPERGILLOSIS IN CYSTIC FIBROSIS

(2010) Joanna Massam et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The Effect of Chronic Infection With Aspergillus fumigatus on Lung Function and Hospitalization in Patients With Cystic Fibrosis

(2009) Reshma Amin et al.   CHEST

Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005

(2009) F.A. Millar et al.   Journal of Cystic Fibrosis

Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis – a review

(2009) Marc Pihet et al.   MEDICAL MYCOLOGY

Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis

(2007) Giuseppe Valenza et al.   Journal of Cystic Fibrosis